TY - JOUR
T1 - Involvement of cathepsin B in the processing and secretion of interleukin-1β in chromogranin a-stimulated microglia
AU - Terada, Kayo
AU - Yamada, Jun
AU - Hayashi, Yoshinori
AU - Wu, Zhou
AU - Uchiyama, Yasuo
AU - Peters, Christoph
AU - Nakanishi, Hiroshi
PY - 2010
Y1 - 2010
N2 - Cathepsin B (CB) is a cysteine lysosomal protease implicated in a number of inflammatory diseases. Although it is now evident that caspase-1, an essential enzyme for maturation of interleukin-1b (IL-1β), can be activated through the inflammasome, there is still evidence suggesting the existence of lysosomal-proinflammatory caspase pathways. In the present study, a marked induction of pro-IL-1β, its processing to the mature form and secretion were observed in the primary cultured microglia prepared from wild-type mice after stimulation with chromogranin A (CGA). Although pro-IL-1β also markedly increased in microglia prepared from CB-deficient mice, CB-deficiency abrogated the pro-IL-1β processing. CA-074Me, a specific inhibitor for CB, inhibited the pro-IL-1β maturation and its release from microglia. Furthermore, the caspase-1 activation was also inhibited by CA-074Me and E-64d, a broad cysteine protease inhibitor. After treatment with CGA, CB was markedly induced at both protein and mRNA levels. The induced pro-CB was rapidly processed to its mature form. The immunoreactivity for CB co-localized with both that for caspase-1 and the cleaved IL-1β, in the acidic enlarged lysosomes. In consistent with these in vitro observations, the immunoreactivity for the cleaved IL-1β was markedly observed in microglia of the hippocampus from aged wild-type but not CB-deficient mice. These observations strongly suggest that CB plays a key role in the pro-IL-1βmaturation through the caspase-1 activation in enlarged lysosomes of CGA-treated microglia. Therefore, either pharmacological or genetic inhibition of CB may provide therapeutic intervention in inflammation-associated neurological diseases.
AB - Cathepsin B (CB) is a cysteine lysosomal protease implicated in a number of inflammatory diseases. Although it is now evident that caspase-1, an essential enzyme for maturation of interleukin-1b (IL-1β), can be activated through the inflammasome, there is still evidence suggesting the existence of lysosomal-proinflammatory caspase pathways. In the present study, a marked induction of pro-IL-1β, its processing to the mature form and secretion were observed in the primary cultured microglia prepared from wild-type mice after stimulation with chromogranin A (CGA). Although pro-IL-1β also markedly increased in microglia prepared from CB-deficient mice, CB-deficiency abrogated the pro-IL-1β processing. CA-074Me, a specific inhibitor for CB, inhibited the pro-IL-1β maturation and its release from microglia. Furthermore, the caspase-1 activation was also inhibited by CA-074Me and E-64d, a broad cysteine protease inhibitor. After treatment with CGA, CB was markedly induced at both protein and mRNA levels. The induced pro-CB was rapidly processed to its mature form. The immunoreactivity for CB co-localized with both that for caspase-1 and the cleaved IL-1β, in the acidic enlarged lysosomes. In consistent with these in vitro observations, the immunoreactivity for the cleaved IL-1β was markedly observed in microglia of the hippocampus from aged wild-type but not CB-deficient mice. These observations strongly suggest that CB plays a key role in the pro-IL-1βmaturation through the caspase-1 activation in enlarged lysosomes of CGA-treated microglia. Therefore, either pharmacological or genetic inhibition of CB may provide therapeutic intervention in inflammation-associated neurological diseases.
UR - http://www.scopus.com/inward/record.url?scp=73349135899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73349135899&partnerID=8YFLogxK
U2 - 10.1002/glia.20906
DO - 10.1002/glia.20906
M3 - Article
C2 - 19544382
AN - SCOPUS:73349135899
SN - 0894-1491
VL - 58
SP - 114
EP - 124
JO - GLIA
JF - GLIA
IS - 1
ER -